Endometrial Cancer: Genetic, Metabolic Characteristics, Therapeutic Strategies and Nanomedicine

Endometrial cancer is the fourth most common malignancy in female population worldwide. It was estimated that 65,620 new cases and 12.590 subsequent deaths occurred in 2020 in the United States. Patients with type II and advanced endometrial cancer do not respond well to the current treatments. Therefore, endometrial cancer should be better understood in order to develop more effective treatments.To provide an overview of genetic, metabolic...